Ousted Director Says Novartis Inflated Famvir's Value
Law360 (November 27, 2007, 12:00 AM EST) -- A former director for Novartis Pharmaceuticals Corp. has sued her former employer, charging that she was fired in retaliation for accusing the company of inflating the future value of the prescription anti-viral medication Famvir.
Carol Shull, the former brand director for Famvir, claims in a lawsuit lodged in New Jersey state court that Novartis decided to exaggerate its future worth when senior managers realized that the $1.63 billion the company paid to acquire the drug was too high. She claims that the company fired her in March in response to her objections.
“As a direct and proximate result of plaintiff's objection...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!